These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 19838486)
21. Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty. De Luca G; Ernst N; Zijlstra F; van 't Hof AW; Hoorntje JC; Dambrink JH; Gosslink AT; de Boer MJ; Suryapranata H J Am Coll Cardiol; 2004 Apr; 43(8):1363-7. PubMed ID: 15093868 [TBL] [Abstract][Full Text] [Related]
22. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial. Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697 [TBL] [Abstract][Full Text] [Related]
23. Low T3 syndrome improves risk prediction of in-hospital cardiovascular death in patients with acute myocardial infarction. Su W; Zhao XQ; Wang M; Chen H; Li HW J Cardiol; 2018 Sep; 72(3):215-219. PubMed ID: 29580665 [TBL] [Abstract][Full Text] [Related]
24. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Lev EI; Kornowski R; Vaknin-Assa H; Porter A; Teplitsky I; Ben-Dor I; Brosh D; Fuchs S; Battler A; Assali A Am J Cardiol; 2008 Jul; 102(1):6-11. PubMed ID: 18572028 [TBL] [Abstract][Full Text] [Related]
25. Prognostic Value of the Thrombolysis in Myocardial Infarction Risk Score in ST-Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction (from the EPHESUS Trial). Popovic B; Girerd N; Rossignol P; Agrinier N; Camenzind E; Fay R; Pitt B; Zannad F Am J Cardiol; 2016 Nov; 118(10):1442-1447. PubMed ID: 27677387 [TBL] [Abstract][Full Text] [Related]
26. Assessment of the prognostic value of coronary angiography in patients with non-ST segment elevation myocardial infarction. Maciejewski P; Lewandowski P; Wąsek W; Budaj A Kardiol Pol; 2013; 71(2):136-42. PubMed ID: 23575706 [TBL] [Abstract][Full Text] [Related]
27. Combination of the Killip and TIMI classifications for early risk stratification of patients with acute ST elevation myocardial infarction. Rott D; Leibowitz D; Schwartz R; Weiss AT; Behar S; Hod H Cardiology; 2010; 117(4):291-5. PubMed ID: 21335969 [TBL] [Abstract][Full Text] [Related]
28. [Mortality of patients with ST-elevation acute myocardial infarction treated with primary angioplasty or thrombolysis]. Greig D; Corbalán R; Castro P; Campos P; Lamich R; Yovaniniz P Rev Med Chil; 2008 Sep; 136(9):1098-106. PubMed ID: 19030652 [TBL] [Abstract][Full Text] [Related]
29. TIMI Risk Score accurately predicts risk of death in 30-day and one-year follow-up in STEMI patients treated with primary percutaneous coronary interventions. Kozieradzka A; Kamiński K; Dobrzycki S; Nowak K; Musiał W Kardiol Pol; 2007 Jul; 65(7):788-95; discussion 796-7. PubMed ID: 17694460 [TBL] [Abstract][Full Text] [Related]
30. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy. Dryja T; Kornacewicz-Jach Z; Goracy J; Przybycień K; Jodko L; Skowronek A; Kurowski M; Zinka E Kardiol Pol; 2006 Jun; 64(6):591-9; discussion 600-1. PubMed ID: 16810577 [TBL] [Abstract][Full Text] [Related]
33. Identification of predictors of inhospital postreperfusion mode of death in patients with acute ST-elevation myocardial infarction. Vaicekavicius E; Navickas R; Survila L; Stuikys V; Janavicius A; Valancius K Medicina (Kaunas); 2010; 46(2):104-12. PubMed ID: 20440083 [TBL] [Abstract][Full Text] [Related]
34. Prolonged QT interval in ST-elevation myocardial infarction and mortality: new prognostic scale with QT, Killip and age. Rivera-Fernández R; Arias-Verdú MD; García-Paredes T; Delgado-Rodríguez M; Arboleda-Sánchez JA; Aguilar-Alonso E; Quesada-García G; Vera-Almazán A J Cardiovasc Med (Hagerstown); 2016 Jan; 17(1):11-9. PubMed ID: 24922196 [TBL] [Abstract][Full Text] [Related]
35. [The relationship between TIMI (thrombolysis in myocardial infarction) risk score and efficacy of conservative or interventional strategy in patients with non-ST-segment elevation acute coronary syndromes]. Zhao MZ; Hu DY; Ma CS; Jiang LQ; Huo Y; Zhu TG; Wang SW; Yan MY Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Nov; 34(11):1001-4. PubMed ID: 17288763 [TBL] [Abstract][Full Text] [Related]
36. Admission wall motion score and quantitative ST-segment depression in the assessment of 30-day mortality in patients with first non-ST-segment elevation acute coronary syndromes. Figueras J; Barrabés JA; Evangelista A; Lidón RM; Gutierrez L; Garcia del Blanco B; Garcia-Dorado D J Am Soc Echocardiogr; 2013 Aug; 26(8):885-92. PubMed ID: 23791114 [TBL] [Abstract][Full Text] [Related]
37. Performance of the Thrombolysis in Myocardial Infarction (TIMI) ST-elevation myocardial infarction risk score in a national cohort of elderly patients. Rathore SS; Weinfurt KP; Foody JM; Krumholz HM Am Heart J; 2005 Sep; 150(3):402-10. PubMed ID: 16169316 [TBL] [Abstract][Full Text] [Related]
38. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes? Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502 [TBL] [Abstract][Full Text] [Related]
39. [Acute myocardial infarction in the thrombolytic era: high mortality in elderly patients]. Polanczyk CA; Prado K; Borges MS; Ribeiro JP Rev Assoc Med Bras (1992); 1993; 39(2):65-72. PubMed ID: 8242104 [TBL] [Abstract][Full Text] [Related]
40. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty. Grabowski M; Filipiak KJ; Malek LA; Karpinski G; Huczek Z; Stolarz P; Spiewak M; Kochman J; Rudowski R; Opolski G Int J Cardiol; 2007 Feb; 115(3):386-90. PubMed ID: 16860415 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]